NYC seed-stage VC investing in biotech, blockchain, AI with focus on longevity and brain health
NYC seed-stage VC investing in biotech, blockchain, AI with focus on longevity and brain health
Key people at Monday Capital.
Monday Capital is a New York City-based seed-stage venture capital firm that invests primarily in biotech, blockchain, and AI startups, with a particular focus on longevity and brain health. Their mission centers on backing founders who envision bold futures and possess the expertise to realize transformative innovations. The firm’s investment philosophy emphasizes supporting companies that challenge conventional thinking and open new possibilities, especially in cutting-edge sectors that address critical health and technological challenges. By concentrating on longevity and brain health, Monday Capital aims to impact the startup ecosystem by fostering breakthroughs that could extend healthy human lifespan and improve cognitive function, thereby addressing significant societal needs.
Founded relatively recently, Monday Capital is led by key partners who bring expertise in their focus areas, evolving their investment approach to target high-impact technologies in biotech and AI. The firm’s origin story reflects a commitment to identifying early-stage companies that combine scientific rigor with visionary leadership, often capturing early traction through pioneering research and innovative product development. This human-centric approach grounds their investment decisions in both technical potential and founder capability.
Monday Capital rides the wave of increasing interest and investment in longevity science, neurotechnology, and AI-driven healthcare solutions. The timing is critical as advances in genomics, AI, and blockchain converge to enable new approaches to aging and brain health. Market forces such as an aging global population, rising healthcare costs, and demand for personalized medicine create fertile ground for startups in these sectors. Monday Capital influences the ecosystem by channeling capital and expertise into early-stage ventures that might otherwise struggle to secure funding, thus accelerating innovation cycles and fostering a community of mission-driven entrepreneurs.
Looking ahead, Monday Capital is poised to deepen its impact by expanding its portfolio in longevity and brain health, potentially integrating emerging technologies like AI-powered diagnostics and blockchain for secure health data management. Trends such as increased longevity research funding, AI advancements, and regulatory support for biotech innovation will shape their journey. Their influence is likely to grow as they help define the frontier of health tech investing, supporting startups that could transform how society approaches aging and cognitive wellness. This aligns with their founding vision of backing bold founders who dare to imagine and build the future of human health.
Key people at Monday Capital.
